View More Recent Stories

Feb 6, 2020 07:30AM Initial Public Offerings on NEO Raised $1.5 Billion In 2019
Oct 25, 2018 08:15AM Halozyme Therapeutics (HALO) Reports First Clinical Dosing In Bristol-Myers Squibb (BMY) Phase 1 Trial Of BMS-986179 With Enhanze Technology
Oct 25, 2018 08:00AM Halozyme Announces First Clinical Dosing In Bristol-Myers Squibb's Phase 1 Trial Of BMS-986179 With Enhanze® Technology
Oct 23, 2018 10:38AM Halo Labs Inc. Opens NEO
Oct 3, 2018 09:30AM Halo Labs Launches On NEO
Sep 14, 2017 07:00AM Bristol-Myers Squibb (BMY), Halozyme (HALO) Enter Pact for ENHANZE Technology
Sep 14, 2017 06:59AM Bristol-Myers Squibb and Halozyme Enter Global Collaboration and License Agreement for ENHANZE Technology
Jun 5, 2014 09:31AM Pre-Open Stock Movers 06/05: (NEWL) (CIEN) (HALO) Higher; (NVAX) (RAD) (RCAP) Lower (more...)
View More Recent Stories